Porreca Angelo, Colicchia Michele, D'Agostino Daniele, Amenta Michele, Corsaro Alfio, Zaramella Stefano, Zegna Luisa, Gallo Fabrizio, Schenone Maurizio, Bozzini Giorgio, Calori Alberto, Pastore Antonio L, Al Salhi Yazan, Sciorio Carmine, Spirito Lorenzo, Varca Virginia, Marenghi Carlo, Greco Francesco, Altieri Vincenzo M, Verze Paolo, Barba Ciro, Antonelli Alessandro, Cerruto Maria A, Falabella Roberto, Di Bello Silvana, Leonardo Costantino, Tufano Antonio, Volpe Alessandro, Umari Paolo, Parma Paolo, Nidini Mattia, Pini Giovannalberto, Borghesi Marco, Terrone Carlo, Cacciamani Giovanni E, Sighinolfi Maria C, Busetto Gian Maria, Wennberg Alexandra M, Finocchiaro Marinella, Falsaperla Mario, Oderda Marco, Ceruti Carlo, Rocco Bernardo, Schiavina Riccardo, Bianchi Lorenzo, Mari Andrea, Di Maida Fabrizio, Dalpiaz Orietta, Celia Antonio, Pirozzi Marco, Bove Pierluigi, Iacovelli Valerio, Cafarelli Angelo, Cindolo Luca, Ferrari Giovanni, Gatti Lorenzo, Pirola Giacomo, Annino Filippo, Pucci Luigi, Romagnoli Daniele, Artibani Walter, Minervini Andrea
Department of Urology, Policlinico Abano Terme, Abano Terme, Italy.
Department of Urology, Policlinico Abano Terme, Abano Terme, Italy,
Urol Int. 2020;104(7-8):631-636. doi: 10.1159/000508512. Epub 2020 May 20.
The coronavirus disease 2019 (COVID-19) pandemic has put a substantial burden on the Italian healthcare system, resulting in the restructuring of hospitals to care for COVID-19 patients. However, this has likely impacted access to care for patients experiencing other conditions. We aimed to quantify the impact of COVID-19 on access to care for patients with urgent/emergent urological conditions throughout Italy.
A questionnaire was sent to 33 urological units in the AGILE consortium, asking clinicians to report on the number of urgent/emergent urological patients seen and/or undergoing surgery over a 3-week period during the peak of the COVID-19 outbreak and a reference week prior to the outbreak. ANOVA and linear regression models were used to quantify these changes.
Data from 27 urological centres in Italy showed a decrease from 956 patients/week seen just prior to the outbreak to 291 patients/week seen by the end of the study period. There was a difference in the number of patients with urgent/emergent urological disease seen within/during the different weeks (all p values < 0.05). A significant decrease in the number of patients presenting with haematuria, urinary retention, urinary tract infection, scrotal pain, renal colic, or trauma and urgent/emergent cases that required surgery was reported (all p values < 0.05).
In Italy, during the COVID-19 outbreak there has been a decrease in patients seeking help for urgent/emergent urological conditions. Restructuring of hospitals and clinics is mandatory to cope with the COVID-19 pandemic; however, the healthcare system should continue to provide adequate levels of care also to patients with other conditions.
2019年冠状病毒病(COVID-19)大流行给意大利医疗系统带来了沉重负担,导致医院进行重组以护理COVID-19患者。然而,这可能影响了患有其他疾病的患者获得医疗服务的机会。我们旨在量化COVID-19对意大利各地急需/紧急泌尿系统疾病患者获得医疗服务的影响。
向AGILE联盟的33个泌尿外科单位发送了一份问卷,要求临床医生报告在COVID-19疫情高峰期的3周内以及疫情爆发前的一个参考周内所诊治和/或接受手术的急需/紧急泌尿系统疾病患者数量。使用方差分析和线性回归模型来量化这些变化。
来自意大利27个泌尿外科中心的数据显示,从疫情爆发前每周诊治956名患者降至研究期结束时每周诊治291名患者。在不同周内/期间诊治的急需/紧急泌尿系统疾病患者数量存在差异(所有p值<0.05)。报告显示,出现血尿、尿潴留、尿路感染、阴囊疼痛、肾绞痛或创伤以及需要手术的急需/紧急病例的患者数量显著减少(所有p值<0.05)。
在意大利,COVID-19疫情期间,寻求急需/紧急泌尿系统疾病治疗的患者数量有所减少。医院和诊所的重组对于应对COVID-19大流行是必要的;然而,医疗系统也应继续为患有其他疾病的患者提供足够水平的护理。